.Pharmacolibrary.Drugs.ATC.N.N02CC08 .Pharmacolibrary.Drugs.ATC.N.N02CC08| name: | Lasmiditan | |
| ATC code: | N02CC08 | route: | oral |
| compartments: | 1 | |
| dosage: | 100 | mg |
| volume of distribution: | 194 | L |
| clearance: | 58.5 | L/h |
| other parameters in model implementation | ||
Lasmiditan is a selective serotonin 5-HT1F receptor agonist used for the acute treatment of migraine with or without aura in adults. It is approved for use in several countries, including the United States.
Pharmacokinetic data following single oral administration in healthy adult volunteers, both male and female.
Martinelli, D, et al., & Tassorelli, C (2021). Lasmiditan: an additional therapeutic option for the acute treatment of migraine. Expert review of neurotherapeutics 21(5) 491–502. DOI:10.1080/14737175.2021.1912599 PUBMED:https://pubmed.ncbi.nlm.nih.gov/33866907